268 related articles for article (PubMed ID: 32826950)
1. ApoC1 promotes the metastasis of clear cell renal cell carcinoma via activation of STAT3.
Li YL; Wu LW; Zeng LH; Zhang ZY; Wang W; Zhang C; Lin NM
Oncogene; 2020 Sep; 39(39):6203-6217. PubMed ID: 32826950
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of Apolipoprotein C1 (APOC1) in Clear Cell Renal Cell Carcinoma and Its Prognostic Significance.
Xiao H; Xu Y
Med Sci Monit; 2021 Feb; 27():e929347. PubMed ID: 33591959
[TBL] [Abstract][Full Text] [Related]
3. Expression of apolipoprotein C1 in clear cell renal cell carcinoma: An oncogenic gene and a prognostic marker.
Wang HJ; Ma YX; Wang AH; Jiang YS; Jiang XZ
Kaohsiung J Med Sci; 2021 May; 37(5):419-426. PubMed ID: 33305507
[TBL] [Abstract][Full Text] [Related]
4. KIF2C promotes clear cell renal cell carcinoma progression via activating JAK2/STAT3 signaling pathway.
Deng H; Gong X; Ji G; Li C; Cheng S
Mol Cell Probes; 2023 Dec; 72():101938. PubMed ID: 37863123
[TBL] [Abstract][Full Text] [Related]
5. Blocking the autocrine regulatory loop of Gankyrin/STAT3/CCL24/CCR3 impairs the progression and pazopanib resistance of clear cell renal cell carcinoma.
Wang C; Wang Y; Hong T; Cheng B; Gan S; Chen L; Zhang J; Zuo L; Li J; Cui X
Cell Death Dis; 2020 Feb; 11(2):117. PubMed ID: 32051393
[TBL] [Abstract][Full Text] [Related]
6. Systematic pan-cancer analysis identifies APOC1 as an immunological biomarker which regulates macrophage polarization and promotes tumor metastasis.
Ren L; Yi J; Yang Y; Li W; Zheng X; Liu J; Li S; Yang H; Zhang Y; Ge B; Zhang S; Fu W; Dong D; Du G; Wang X; Wang J
Pharmacol Res; 2022 Sep; 183():106376. PubMed ID: 35914680
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of ERp57 promotes clear cell renal cell carcinoma progression by initiating a STAT3/ILF3 feedback loop.
Liu Y; Wang JX; Nie ZY; Wen Y; Jia XJ; Zhang LN; Duan HJ; Shi YH
J Exp Clin Cancer Res; 2019 Oct; 38(1):439. PubMed ID: 31747963
[TBL] [Abstract][Full Text] [Related]
8. MIOX inhibits autophagy to regulate the ROS -driven inhibition of STAT3/c-Myc-mediated epithelial-mesenchymal transition in clear cell renal cell carcinoma.
Meng L; Gao J; Mo W; Wang B; Shen H; Cao W; Ding M; Diao W; Chen W; Zhang Q; Shu J; Dai H; Guo H
Redox Biol; 2023 Dec; 68():102956. PubMed ID: 37977044
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA MRCCAT1 promotes metastasis of clear cell renal cell carcinoma via inhibiting NPR3 and activating p38-MAPK signaling.
Li JK; Chen C; Liu JY; Shi JZ; Liu SP; Liu B; Wu DS; Fang ZY; Bao Y; Jiang MM; Yuan JH; Qu L; Wang LH
Mol Cancer; 2017 Jun; 16(1):111. PubMed ID: 28659173
[TBL] [Abstract][Full Text] [Related]
10. High-level S100A6 promotes metastasis and predicts the outcome of T1-T2 stage in clear cell renal cell carcinoma.
Lyu X; Li H; Ma X; Li X; Gao Y; Ni D; Shen D; Gu L; Wang B; Zhang Y; Zhang X
Cell Biochem Biophys; 2015 Jan; 71(1):279-90. PubMed ID: 25120023
[TBL] [Abstract][Full Text] [Related]
11. VHL mutation-mediated SALL4 overexpression promotes tumorigenesis and vascularization of clear cell renal cell carcinoma via Akt/GSK-3β signaling.
Sun J; Tang Q; Gao Y; Zhang W; Zhao Z; Yang F; Hu X; Zhang D; Wang Y; Zhang H; Song B; Zhang B; Wang H
J Exp Clin Cancer Res; 2020 Jun; 39(1):104. PubMed ID: 32513235
[TBL] [Abstract][Full Text] [Related]
12. ApoC1 promotes glioma metastasis by enhancing epithelial-mesenchymal transition and activating the STAT3 pathway.
Liang R; Zhang G; Xu W; Liu W; Tang Y
Neurol Res; 2023 Mar; 45(3):268-275. PubMed ID: 36302088
[TBL] [Abstract][Full Text] [Related]
13. miR-122 promotes metastasis of clear-cell renal cell carcinoma by downregulating Dicer.
Fan Y; Ma X; Li H; Gao Y; Huang Q; Zhang Y; Bao X; Du Q; Luo G; Liu K; Meng Q; Zhao C; Zhang X
Int J Cancer; 2018 Feb; 142(3):547-560. PubMed ID: 28921581
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of FOXO3a promotes tumor metastasis and is associated with metastasis-free survival of patients with clear cell renal cell carcinoma.
Ni D; Ma X; Li HZ; Gao Y; Li XT; Zhang Y; Ai Q; Zhang P; Song EL; Huang QB; Fan Y; Zhang X
Clin Cancer Res; 2014 Apr; 20(7):1779-90. PubMed ID: 24486593
[TBL] [Abstract][Full Text] [Related]
15. HAVCR/KIM-1 activates the IL-6/STAT-3 pathway in clear cell renal cell carcinoma and determines tumor progression and patient outcome.
Cuadros T; Trilla E; Sarró E; Vilà MR; Vilardell J; de Torres I; Salcedo M; López-Hellin J; Sánchez A; Ramón y Cajal S; Itarte E; Morote J; Meseguer A
Cancer Res; 2014 Mar; 74(5):1416-28. PubMed ID: 24390735
[TBL] [Abstract][Full Text] [Related]
16. CD103-positive CSC exosome promotes EMT of clear cell renal cell carcinoma: role of remote MiR-19b-3p.
Wang L; Yang G; Zhao D; Wang J; Bai Y; Peng Q; Wang H; Fang R; Chen G; Wang Z; Wang K; Li G; Yang Y; Wang Z; Guo P; Peng L; Hou D; Xu W
Mol Cancer; 2019 Apr; 18(1):86. PubMed ID: 30975145
[TBL] [Abstract][Full Text] [Related]
17. Dicer is down-regulated in clear cell renal cell carcinoma and in vitro Dicer knockdown enhances malignant phenotype transformation.
Ma X; Fan Y; Gao Y; Zhang Y; Huang Q; Ai Q; Ni D; Chen W; Zhang P; Song E; Wang B; Shi T; Zheng T; Zhang X
Urol Oncol; 2014 Jan; 32(1):46.e9-17. PubMed ID: 24094887
[TBL] [Abstract][Full Text] [Related]
18. Exosomal AP000439.2 from clear cell renal cell carcinoma induces M2 macrophage polarization to promote tumor progression through activation of STAT3.
Shen T; Miao S; Zhou Y; Yi X; Xue S; Du B; Tang C; Qu L; Fu D; Jia R; He H
Cell Commun Signal; 2022 Sep; 20(1):152. PubMed ID: 36153596
[TBL] [Abstract][Full Text] [Related]
19. Cyclovirobuxine inhibits the progression of clear cell renal cell carcinoma by suppressing the IGFBP3-AKT/STAT3/MAPK-Snail signalling pathway.
Liu Y; Lv H; Li X; Liu J; Chen S; Chen Y; Jin Y; An R; Yu S; Wang Z
Int J Biol Sci; 2021; 17(13):3522-3537. PubMed ID: 34512163
[TBL] [Abstract][Full Text] [Related]
20. ETV4 is a theranostic target in clear cell renal cell carcinoma that promotes metastasis by activating the pro-metastatic gene FOSL1 in a PI3K-AKT dependent manner.
Xu L; Hu H; Zheng LS; Wang MY; Mei Y; Peng LX; Qiang YY; Li CZ; Meng DF; Wang MD; Liu ZJ; Li XJ; Huang BJ; Qian CN
Cancer Lett; 2020 Jul; 482():74-89. PubMed ID: 32305558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
